Yi Tang

Title: Yi Tang: Innovator in Antibody Development

Introduction

Yi Tang is a prominent inventor based in Radnor, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target human CD147. His work is crucial in addressing malignant diseases and related health issues.

Latest Patents

Yi Tang holds a patent for "Anti-CD147 antibodies, methods and uses." This invention provides antibodies that are immunospecific for human CD147, which can block the bioactivity of CD147 associated with malignant diseases. The antibodies are designed to inhibit the stimulation of matrix metalloproteinases (MMPs) from fibroblast cells by tumor cells, the release of vascular endothelial growth factor (VEGF), and the promotion of angiogenesis. This innovation is particularly useful in treating malignant diseases and conditions where CD147 activity plays a pathogenic role, including diseases of the eye, lung, and cardiovascular system. He has 1 patent to his name.

Career Highlights

Yi Tang is associated with Centocor Ortho Biotech Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, focusing on therapeutic solutions for serious health conditions.

Collaborations

Some of his notable coworkers include Mark Hilary Cunningham and Bethany Swencki-Underwood. Their collaborative efforts contribute to the innovative environment at Centocor Ortho Biotech Inc.

Conclusion

Yi Tang's contributions to the field of biotechnology, particularly through his patent on anti-CD147 antibodies, highlight his role as an innovator in addressing critical health challenges. His work continues to pave the way for advancements in the treatment of malignant diseases.